IN2014DN10134A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10134A
IN2014DN10134A IN10134DEN2014A IN2014DN10134A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A IN 10134DEN2014 A IN10134DEN2014 A IN 10134DEN2014A IN 2014DN10134 A IN2014DN10134 A IN 2014DN10134A
Authority
IN
India
Prior art keywords
vesicular
active agent
biologically active
formulation
administering
Prior art date
Application number
Other languages
English (en)
Inventor
Richard Wolf Garraway
John Mayo
William Henry
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Publication of IN2014DN10134A publication Critical patent/IN2014DN10134A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN10134DEN2014 2012-05-14 2013-05-10 IN2014DN10134A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208384A GB201208384D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, uses and methods
PCT/EP2013/059740 WO2013171131A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, uses and methods

Publications (1)

Publication Number Publication Date
IN2014DN10134A true IN2014DN10134A (sr) 2015-08-21

Family

ID=46458741

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10134DEN2014 IN2014DN10134A (sr) 2012-05-14 2013-05-10

Country Status (9)

Country Link
US (1) US20150125407A1 (sr)
EP (1) EP2849721A1 (sr)
JP (1) JP2015516453A (sr)
CN (1) CN104411298A (sr)
DE (1) DE112013002492T5 (sr)
GB (1) GB201208384D0 (sr)
HK (1) HK1209027A1 (sr)
IN (1) IN2014DN10134A (sr)
WO (1) WO2013171131A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ598906A (en) 2009-08-21 2014-08-29 Targeted Delivery Technologies Ltd Vesicular formulations
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
LT3316857T (lt) 2015-06-30 2021-11-25 Sequessome Technology Holdings Limited Daugiafazės kompozicijos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238554A4 (en) * 1985-09-27 1987-10-27 Univ California LIPOSOME SYSTEM FOR TRANSDERMAL DRUG ADMINISTRATION.
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
CA2067754C (en) 1990-08-24 2002-06-04 Gregor Cevc Preparation for the application of agents in mini-droplets
JPH06293615A (ja) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd 混合脂質膜小胞を含有する化粧品
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
WO2008070538A2 (en) * 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
ES2335636B1 (es) * 2008-02-29 2011-05-11 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica de micelas mixtas.
LT2437726T (lt) 2009-06-03 2018-09-10 Sequessome Technology Holdings Limited Kompozicijos, skirtos giliųjų audinių skausmo gydymui
NZ598906A (en) 2009-08-21 2014-08-29 Targeted Delivery Technologies Ltd Vesicular formulations

Also Published As

Publication number Publication date
CN104411298A (zh) 2015-03-11
GB201208384D0 (en) 2012-06-27
DE112013002492T5 (de) 2015-02-19
EP2849721A1 (en) 2015-03-25
JP2015516453A (ja) 2015-06-11
US20150125407A1 (en) 2015-05-07
HK1209027A1 (en) 2016-03-24
WO2013171131A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX364992B (es) Moduladores del transporte nuclear y usos de los mismos.
MX2013001677A (es) Formulaciones estables de linaclotida.
MX369121B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
NZ631144A (en) Compositions and methods for transmucosal absorption
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX2014008284A (es) Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ718163A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2013008175A (es) Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
PH12014502619A1 (en) Novel dosage and formulation
PH12016500142A1 (en) Vesicles
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
IN2014DN10134A (sr)
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
IN2014CN04119A (sr)
PH12015500070B1 (en) Pediatric oral liquid compositions containing nepadutant
EA201690113A1 (ru) Везикулы